Cargando…

p53 Mutations in Two Patients with Intraductal Papillary Adenoma of the Pancreas

There has been no report on p53 gene mutation in benign human pancreatic intraductal tumors. We examined pancreatic juice and tissue specimens from two patients with intraductal papillary adenoma of the pancreas by polymerase chain reaction‐single‐strand conformation polymorphism analysis and direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaino, Miyuki, Kondoh, Satoshi, Okita, Satoshi, Ryozawa, Syomei, Hatano, Satoko, Shiraishi, Kei, Kaino, Seiji, Akiyama, Tetsuji, Okita, Kiwamu, Kawano, Toyokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921029/
https://www.ncbi.nlm.nih.gov/pubmed/9045952
http://dx.doi.org/10.1111/j.1349-7006.1996.tb03132.x
Descripción
Sumario:There has been no report on p53 gene mutation in benign human pancreatic intraductal tumors. We examined pancreatic juice and tissue specimens from two patients with intraductal papillary adenoma of the pancreas by polymerase chain reaction‐single‐strand conformation polymorphism analysis and direct sequencing and found point mutations of p53 gene resulting in amino acid substitutions in exons 6 and 8. Thus, p53 gene mutation may be an early event in the neoplastic process of some pancreatic intraductal tumors and may play an important role in tumorigenesis.